Cu(II) partially protects three histidine residues and the N-terminus of amyloid-β peptide from diethyl pyrocarbonate (DEPC) modificationFriedemann, Merlin; Tõugu, Vello; Palumaa, PeepFEBS Open Bio2020 / p. 1072-1081 https://doi.org/10.1002/2211-5463.12857 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS Discordance between amyloid-β PET and CSF biomarkers : clinical and pathophysiological consequences = Amüloid-β staatuse vastuolu PET-uuringul ning liikvorianalüüsil : kliiniline ja patofüsioloogiline tähendusReimand, Juhan2021 https://doi.org/10.23658/taltech.15/2021 https://www.ester.ee/record=b5431268*est https://digikogu.taltech.ee/et/Item/d14a365f-fbfc-4595-923e-473262485fe2 Discordant amyloid-β PET and CSF biomarkers and its clinical consequencesWilde, Arno de; Reimand, Juhan; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 78, 13 p. : ill https://doi.org/10.1186/s13195-019-0532-x Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS Doktoritöö aitab lahendada Alzheimeri diagnoosimisega seotud vastuolusid [Võrguväljaanne]Oidermaa, Jaan-Juhannovaator.err.ee2021 "Doktoritöö aitab lahendada Alzheimeri diagnoosimisega seotud vastuolusid" Mercury and Alzheimer’s disease: Hg(II) ions display specific binding to the amyloid-β peptide and hinder its fibrillizationWallin, Cecilia; Friedemann, Merlin; Sholts, Sabrina B.; Noormägi, Andra; Svantesson, Teodor; Järvet, Jüri; Roos, Per M.; Palumaa, Peep; Gräslund, Astrid; Wärmländer, Sebastian K.T.S.Biomolecules2020 / art. 44, 23 p. : ill https://doi.org/10.3390/biom10010044 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS Postponing aging and prolonging life expectancy with the knowledge-based economyKristjuhan, ÜloRejuvenation research2012 / p. 132-133 https://www.liebertpub.com/doi/abs/10.1089/rej.2011.1252?journalCode=rej USAs anti roheline tuli esimesele Alzheimeri ravimile 20 aasta jooksul [Võrguväljaanne]Voltri, Johannesnovaator.err.ee2021 "USAs anti roheline tuli esimesele Alzheimeri ravimile 20 aasta jooksul"